4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-072153
Chief Operating Officer sold 85,270 shares at an average $30.30 ($2,583,782)
- Chief Operating Officer acquired 80,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-10 | Option exercise 10b5-1 | +80,000 | $5.54 | $443,200 | 234,062 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-10 | Sale 10b5-1 | −80,000 | $30.24 | $2,419,200 | 154,062 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-11 | Sale 10b5-1 | −2,357 | $31.23 | $73,609 | 151,705 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-11 | Sale 10b5-1 | −2,913 | $31.23 | $90,973 | 148,792 | D |
| Derivatives | |||||||
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-06-10 | Option exercise · Stock option (right to buy) 10b5-1 | −80,000 | 140,486 | D | ||
| Open-market sales · 85,270 sh · avg $30.30 · $2,583,782 | |||||||
Loading xslF345X05/ownership.xml…